2 months Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in Stock MarketBeat

Pfizer Inc. (NYSE:PFE – Get Free Report) Director Scott Gottlieb acquired 1,000 shares of the stock in a transaction on Wednesday, October 30th. The stock was bought at an average price of $28.24 per share, with a total value of $28,240.00. Following t…

NYSE · Pfizer (PFE)

2 months Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in Stock MarketBeat

21 hours Ford, GM Would Be Hurt By End Of EV Tax Credit 24/7 Wall St.

2 days Bank of America Just Paid Investors: Here’s How Much They Got 24/7 Wall St.

3 days Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

3 days Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

3 days Tariffs Could Hurt Ford’s Inexpensive Car Sales 24/7 Wall St.

3 days Walmart Stock Surges as Other Retailers Crumble 24/7 Wall St.

3 days NYSE short interest rose 2.4 percent in mid-December Investing.com

4 days Toyota Shares Crippled By Industry Challenges 24/7 Wall St.

4 days Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

4 days Volato resolves noncompliance with NYSE Yahoo Finance

4 days Better Income Stock: Pfizer or Altria Group? Yahoo Finance

5 days NYSE short interest rose 2.4 percent in mid-December Investing.com

5 days Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

5 days Ford and Honda Are Car Market Losers 24/7 Wall St.

6 days Should Value Investors Buy Pfizer (PFE) Stock? Zacks

6 days ‘The Container Store is here to stay,’ vows CEO in Chapter 11 bankruptcy announcement, but will stores close? Fast Company

6 days Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

6 days SCHD vs VIG: Which Dividend ETF Should Retirees Buy? 24/7 Wall St.

6 days SPAC Copley Acquisition eyes US$150 million NYSE IPO, seeks targets in tech, lifestyle sectors Yahoo Finance

6 days Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

1 week Ford Drops Below $10 24/7 Wall St.

1 week Almacenes Éxito to Delist from NYSE and Focus on Colombian Market Yahoo Finance

1 week If You Bought 1 Share of Berkshire Hathaway When It Joined the New York Stock Exchange, Here’s How Many Shares You Would Own Now Yahoo Finance

1 week LNG producer Venture Global files for IPO on NYSE Yahoo Finance

1 week Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

1 week Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

1 week Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? Zacks

1 week SEC simultaneously approves Hashdex, Franklin’s Bitcoin-Ether ETFs Cointelegraph

1 week Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

1 week Iron Mountain Stock Declines 10.5% in 3 Months: Buy, Hold or Sell? Zacks

2 weeks Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

2 weeks Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

2 weeks Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

2 weeks Is Walmart Spying on Shoppers? 24/7 Wall St.

2 weeks Ford and GM Should Benefit From Jump in Car Sales 24/7 Wall St.

2 weeks Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

2 weeks Why these two pharma stocks are surging FXStreet

2 weeks Final Trade: GOOG, SAIA, X, PFE YouTube

2 weeks Pfizer climbs 4% on 2025 outlook YouTube

2 weeks Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

2 weeks Buffett May Have Made a Big Mistake with Apple (AAPL) Stock 24/7 Wall St.

2 weeks Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

2 weeks Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

2 weeks Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

2 weeks Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

2 weeks Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

2 weeks Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

2 weeks Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

2 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

2 weeks Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

The Stock Market News